Share this post on:

Product Name :
Anamorelin Hydrochloride

Search keywords :
Anamorelin (hydrochloride)

drugId :
null

Target Vo:
Ghrelin/growth hormone secretagogue receptor

Target Vo Short Name :
GHSR

Moa_Name:
Ghrelin/growth hormone secretagogue receptor agonists

First Approval Country :
Japan

First Approval Date Filter:
2021

Origin Company_Name :
Novo Nordisk A/S

Active Company_Name :
Helsinn Birex Pharmaceuticals Ltd

Active Indication_Name:
Cachexia

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tocilizumab Data Sheet
MLKL Rabbit mAb manufacturer
Flotillin 1 Antibody (YA760): Flotillin 1 Antibody (YA760) is a non-conjugated and Mouse origined monoclonal antibody about 47 kDa, targeting to Flotillin 1 (6H9). It can be used for WB assays with tag free, in the background of Mouse, Rat.

Share this post on:

Author: Interleukin Related